Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. (LYEL) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 53 transactions totaling $673.0K, demonstrating a bearish sentiment with -$73.0K in net insider flow. The most recent transaction on Feb 10, 2026 involved a transaction of 50,000 shares valued at $0.
LYEL Insider Activity Summary
Who Is Buying LYEL Stock?
No significant insider buying has been recorded for LYEL in the recent period.
Who Is Selling LYEL Stock?
No significant insider selling has been recorded for LYEL in the recent period.
Is Lyell Immunopharma, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for LYEL is bearish with an Insider Alignment Score of 45/100 and a net flow of -$73.0K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
LYEL Frequently Asked Questions
Understanding LYEL Insider Activity
Insider trading at Lyell Immunopharma, Inc. (LYEL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading LYEL stock, having executed 53 transactions in the past 90 days. The most active insider is Cathy Friedman (Executive), who has made 4 transactions totaling $300.0K.
Related Tools
Track Lyell Immunopharma, Inc. Insider Activity
Get notified when executives and directors at LYEL file new Form 4 transactions